Last Name | Organization | Clinical Trials | State / Region | Country |
---|---|---|---|---|
Eugenio Zapata-Aldana | London Health Science Centre | Canada | ||
Andrea Swenson
Principal Investigator |
University of Iowa | Iowa | United States | |
Kara Steijlen
Principal Investigator |
Henry Ford Hospital | Michigan | United States | |
Zachary Simmons
Principal Investigator |
Penn State Hershey Medical Center | Pennsylvania | United States | |
Jennifer Roan | United States | |||
Patricia Riley | CSL Behring | MG-SCIg (ends 2022) | Minnesota | United States |
Colin Quinn
|
Select a Country | |||
Richard Nowak
Principal Investigator |
Yale University School of Medicine | EPITOME II (ends 2020) | Connecticut | United States |
Nataly Montes-Chinea | United States | |||
Margherita Milone | Mayo Clinic | Minnesota | United States | |
Janice Massey
|
Select a Country | |||
Veronica Martin
Study Coordinator |
University of California, Irvine | Methotrexa (ends 2019), Rasagiline (ends 2021) | California | United States |
Jean Mah
|
Select a Country | |||
Jau-Shin Lou
Principal Investigator |
Sanford Health | North Dakota | United States | |
Chamindra Konersman | University of California, San Diego | California | United States | |
Chafic Karam
Principal Investigator |
Oregon health science university | Rasagiline (ends 2021) | Oregon | United States |
Yessar Hussain
Principal Investigator |
Austin Neuromuscular Center | Rasagiline (ends 2021), n/a | Texas | United States |
James Howard
Principal Investigator |
University of North Carolina at Chapel Hill | FOR-DMD (ends 2024), Methotrexa (ends 2019) | North Carolina | United States |
Michael Hehir
Principal Investigator |
University of Vermont Larner College of Medicine | EPITOME I (ends 2018) | Vermont | United States |
Neelam Goyal
Principal Investigator |
Stanford University | California | United States |